Medical center building
News | Cardiovascular Business
GE Healthcare and Medtronic Announce Collaboration to Meet Growing Need for Outpatient Care
April 29, 2022 – Providing excellent care inside and outside of the traditional hospital is the new normal for patients ...
Home April 29, 2022
Home
HIMSS22 showed that the industry is back on track, with leading organizations showcasing solutions for staff shortages and related burnout, cybersecurity, digital transformation, image convergence and efficiency
Feature | Cardiovascular Business | By Melinda Taschetta-Millane
Reimagining Health at HIMSS22

You could feel the energy and excitement at the 2022 HIMSS Global Health Conference & Exhibition (HIMSS22) held this ...

Home April 29, 2022
Home
Approval based on groundbreaking Phase 3 EXPLORER-HCM trial demonstrating benefit in patients receiving Camzyos versus placebo
News | Pharmaceuticals
FDA Approves Bristol Myers' Camzyos (mavacamten) Oral Heart Disease Drug

April 29, 2022 — Bristol Myers Squibb announced that the U.S. Food and Drug Administration (FDA) approved Camzyos ...

Home April 29, 2022
Home
During a Philips international media roundtable at HIMSS22, Mandi Bishop, vice president analyst at Gartner, a technological research and consulting firm, presented the trends and top predictions in healthcare and life sciences for 2022.
Blog | Cardiovascular Business
The Digital Divide

During a Philips international media roundtable at HIMSS22, Mandi Bishop, vice president analyst at Gartner, a ...

Home April 29, 2022
Home
The U.S. Food and Drug Administration (FDA) is alerting healthcare providers to the possibility that patients who have the Medtronic Heartware Ventricular Assist Device (HVAD) System and appear to present with pump thrombosis may have a welding defect in the internal pump causing the pump to malfunction.
News | Ventricular Assist Devices (VAD)
FDA Alert: Potential for Internal Pump Malfunction in the Medtronic HVAD System

April 28, 2022 — The U.S. Food and Drug Administration (FDA) is alerting healthcare providers to the possibility that ...

Home April 28, 2022
Home
Aspirin therapy, as opposed to statin use, for non-obstructive coronary artery disease does not reduce major cardiovascular events, according to a new study published in the journal Radiology: Cardiothoracic Imaging.
News | CT Angiography (CTA)
Aspirin Does Not Cut Risk in Non-Obstructive Coronary Artery Disease

April 28, 2022 — Aspirin therapy, as opposed to statin use, for non-obstructive coronary artery disease does not reduce ...

Home April 28, 2022
Home
Today, the Department of Health and Human Services (HHS), through the Centers for Medicare & Medicaid Services (CMS), announced new measures that will allow consumers to more easily find the right form of quality, affordable health care coverage on HealthCare.gov that best meets their needs.
News | Cardiovascular Business
HHS Announces New Policy to Make Coverage More Accessible and Affordable for Millions of Americans in 2023

April 28, 2022 — Today, the Department of Health and Human Services (HHS), through the Centers for Medicare & Medicaid ...

Home April 28, 2022
Home
This ERC Advanced Grant is awarded to scientists with more than ten years of research experience who have already played a prominent role in their field.
News | Heart Failure
MDC Receives ERC Advanced Grant for Cardiac Research
April 27, 2022 – The contractile and elastic properties of the heart are finely tuned. This is a prerequisite for the ...
Home April 27, 2022
Home
Omega Medical Imaging has announced the release of the revolutionary Soteria.AI.
News | Interventional Radiology
Omega Introduces Soteria.AI Interventional Cardiology System

April 27, 2022 – Omega Medical Imaging has announced the release of the revolutionary Soteria.AI. Designed specifically ...

Home April 27, 2022
Home
Medtronic Harmony FDA recall The FDA has identified this as a Class I recall, the most serious type of recall
News | Heart Valve Technology
Medtronic Recalls Harmony Delivery Catheter, Part of TPV System, for Risk of Capsule Break During Use

April 27, 2022 — The U.S. Food and Drug Administration (FDA) has issued a Class I recall for the Medtronic Harmony ...

Home April 27, 2022
Home
CathVision, a medical technology company developing innovative electrophysiology solutions designed to guide and enhance cardiac ablation therapy through the acquisition of low-noise, high-fidelity electrograms, announced the completion of patient enrollment in the CathVision ECGenius System clinical evaluation study at the University of Vermont Medical Center.
News | EP Lab
CathVision Announces Completion of Patient Enrollment at First U.S. Clinical Trial Evaluating High-Fidelity, Low-Noise EP Recording Technology

April 27, 2022 – CathVision, a medical technology company developing innovative electrophysiology solutions designed to ...

Home April 27, 2022
Home
The U.S. Preventive Services Task Force (USPSTF) has released its final recommendations on low-dose aspirin therapy for the primary prevention of cardiovascular disease in adults
News | Stroke
New USPSTF Guidance: Continue to Take Low-Dose Aspirin if you have a History of Heart Attack, AFib, Stroke or Vascular Stenting
April 27, 2022 – The U.S. Preventive Services Task Force (USPSTF) has released its final recommendations on low-dose ...
Home April 27, 2022
Home
The Boston University-led team behind the gadget—nicknamed miniPUMP, and officially known as the cardiac miniaturized Precision-enabled Unidirectional Microfluidic Pump—says the technology could also pave the way for building lab-based versions of other organs, from lungs to kidneys.
News | Artificial Heart
New Miniature Heart Could Help Speed Heart Disease Cures

April 25, 2022 – There’s no safe way to get a close-up view of the human heart as it goes about its work: you can’t just ...

Home April 25, 2022
Home
Pfizer is voluntarily recalling five (5) lots of Accupril (Quinapril HCl) tablets distributed by Pfizer to the patient (consumer/user) level due to the presence of a nitrosamine, Nnitroso-quinapril, observed in recent testing above the Acceptable Daily Intake (ADI) level.
News | Heart Failure
Pfizer Issues Voluntary Nationwide Recall of ACCUPRIL (Quinapril HCl)

April 25, 2022 — Pfizer is voluntarily recalling five (5) lots of Accupril (Quinapril HCl) tablets distributed by Pfizer ...

Home April 25, 2022
Home
Researchers at the National Cerebral and Cardiovascular Center in Japan found that patients aged ≥75 years with non-valvular atrial fibrillation (NVAF) and previous stroke/transient ischemic attack (TIA) more commonly had subsequent ischemic and hemorrhagic events than those without previous stroke/TIA in the prospective, multicenter, observational All Nippon AF In the Elderly (ANAFIE) Registry.
News | Stroke
Elderly NVAF Patients with Previous Stroke Need to be More Cautious for Stroke Recurrence
April 25, 2022 – Researchers at the National Cerebral and Cardiovascular Center in Japan found that patients aged ≥75 ...
Home April 25, 2022
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now